Bortezomib-Based First Line Treatment for AL Amyloidosis Patients Who Are Not Candidate for Stem Cell TransplantaionJoon Young Hur, Kihyun Kım, Kang-Kook Lee et al.|Blood|2018Cited by 1
Phase II Efficacy and Safety of Pembrolizumab with Platinum Based Chemotherapy in Non-Small Cell Lung Cancer Patients with Untreated, Asymptomatic Brain Metastasis (PHOEBS)J KIM, Myung-Ju Ahn, Hyun Ae Jung et al.|Cancer Research and Treatment|2026Cited by 0